These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


128 related items for PubMed ID: 14185789

  • 21. [CLINICAL INVESTIGATIONS IN THE TUBERCULAR FIELD ON RIFAMYCIN SV ADMINISTERED BY VENOUS PERFUSION].
    LUCCHESI M.
    Chemotherapia (Basel); 1963; 12():514-25. PubMed ID: 14185778
    [No Abstract] [Full Text] [Related]

  • 22. [THE ROUTES AND METHODS OF ADMINISTRATION OF RIFAMYCIN SV. THE TOLERANCE OF THE BODY].
    NITTI V.
    Chemotherapia (Basel); 1963; 12():482-91. PubMed ID: 14185774
    [No Abstract] [Full Text] [Related]

  • 23. [USE AND ACTION OF THE NEW ANTIBIOTIC RIFAMYCIN SV (RIFOCIN)].
    ANSCHEL R.
    Wien Med Wochenschr; 1965 Mar 06; 115():197-202. PubMed ID: 14260791
    [No Abstract] [Full Text] [Related]

  • 24. [RESEARCH ON THE BEHAVIOR OF TUBERCULIN ALLERGY DURING TREATMENT WITH RIFAMYCIN SV].
    NINNI A, MARCATILI S.
    Arch Tisiol Mal Appar Respir; 1964 Mar 06; 19():191-205. PubMed ID: 14153331
    [No Abstract] [Full Text] [Related]

  • 25. [CLINICAL TOLERANCE OF RIFAMYCIN SV ADMINISTERED BY VENOUS PERFUSION. (RESEARCH ON THE USE OF SOLUTIONS CONTAINING OR WITHOUT POLYVINYLPYRROLIDONE AND ON THE ASSOCIATION WITH PARA-AMINOSALYCILIC ACID)].
    NINNI A, GALDIERI R.
    Arch Tisiol Mal Appar Respir; 1964 Oct 06; 19():832-56. PubMed ID: 14265719
    [No Abstract] [Full Text] [Related]

  • 26. [FIRST EXPERIENCES IN THE USE OF RIFAMYCIN SV ASSOCIATED WITH PAS USING THE METHOD OF VENOUS PERFUSION. CLINICAL CONTRIBUTION].
    CURCI G, MAURO G.
    Minerva Med; 1964 Dec 12; 55():3964-7. PubMed ID: 14247991
    [No Abstract] [Full Text] [Related]

  • 27. [LOCAL USE OF RIFOMYCIN-SV (RF-SV) IN PULMONARY TUBERCULOSIS. PRELIMINARY COMMUNICATION].
    CUCCHIANIACEVEDO R, LERNER S, FIORINO AR, IRURZUN A.
    Arch Argent Tisiol Neumonol; 1963 Dec 12; 39():159-63. PubMed ID: 14126676
    [No Abstract] [Full Text] [Related]

  • 28. [CONTINUOUS DRAINAGE AND LOCAL APPLICATION OF RIFAMYCIN SV IN CHRONIC OSTEOMYELITIS].
    BIANCHIMAIOCCHI A.
    Chemotherapia (Basel); 1963 Dec 12; 27():344-9. PubMed ID: 14128796
    [No Abstract] [Full Text] [Related]

  • 29. [CLINICAL EVALUATION OF RIFAMYCIN SV IN THE TREATMENT OF HEPATOBILIARY INFECTIONS].
    CRISCUOLO E, PARAJE R, BAISTROCCHI D.
    Chemotherapia (Basel); 1963 Dec 12; 12():448-56. PubMed ID: 14185770
    [No Abstract] [Full Text] [Related]

  • 30. [Rifamycin SV in tuberculosis].
    MONALDI V.
    Arch Tisiol Mal Appar Respir; 1963 Mar 12; 18():345-8. PubMed ID: 13935980
    [No Abstract] [Full Text] [Related]

  • 31. [PRELIMINARY STUDIES ON RIFAMYCIN SV].
    ORREGOPUELMA H, FONTECILLA O, BOTTESELLE O, MARTINO RD, SANTIVIAGO C.
    Chemotherapia (Basel); 1963 Mar 12; 12():506-13. PubMed ID: 14185777
    [No Abstract] [Full Text] [Related]

  • 32. [1st experimental and clinical investigations on rifamycin SV in tuberculosis].
    LUCCHESI M.
    Arch Tisiol Mal Appar Respir; 1963 Mar 12; 18():295-9. PubMed ID: 13931422
    [No Abstract] [Full Text] [Related]

  • 33. [RIFOMYCIN SV IN LABORATORY TESTS].
    NINNI A.
    Arch Tisiol Mal Appar Respir; 1963 Oct 12; 18():919-44. PubMed ID: 14097338
    [No Abstract] [Full Text] [Related]

  • 34. [Contribution to the experimental study of the antitubercular activity of rifamycin SV].
    RIST N, GRUMBACH F.
    Arch Tisiol Mal Appar Respir; 1963 Mar 12; 18():304-5. PubMed ID: 13974058
    [No Abstract] [Full Text] [Related]

  • 35. [Clinical observations of the use of rifamycin SV in tuberculous processes].
    MAZZINI C, GIACHI R.
    Arch Tisiol Mal Appar Respir; 1963 Mar 12; 18():334-5. PubMed ID: 13934258
    [No Abstract] [Full Text] [Related]

  • 36. RIFAMYCIN SV IN POST-OSTEOMYELITIS FISTULAS AND POSTOPERATIVE FISTULAS IN HEPATOBILIARY SURGERY.
    OJEDAGIL J.
    Chemotherapia (Basel); 1963 Mar 12; 12():461-5. PubMed ID: 14191929
    [No Abstract] [Full Text] [Related]

  • 37. [Rifomycin SV in clinical practice. Preliminary data on its therapeutic value in the tubercular field].
    MONALDI V.
    Arch Tisiol Mal Appar Respir; 1961 Dec 12; 16():1013-22. PubMed ID: 14475322
    [No Abstract] [Full Text] [Related]

  • 38. [Rifamycin SV in the local treatment of pulmonary tuberculosis].
    VILARDO S, ZOTTOLA V.
    Arch Tisiol Mal Appar Respir; 1963 Mar 12; 18():338-9. PubMed ID: 13997234
    [No Abstract] [Full Text] [Related]

  • 39. [OBSERVATIONS ON THE USE OF RIFAMYCIN SV IN OSTEOARTICULAR INFECTIONS].
    PICCHIO AA.
    Chemotherapia (Basel); 1963 Mar 12; 10():645-9. PubMed ID: 14184803
    [No Abstract] [Full Text] [Related]

  • 40. [Rifamycin SV in the therapy of tuberculous empyema].
    SONAGLIONI F, GUIDI V.
    Arch Tisiol Mal Appar Respir; 1963 Mar 12; 18():248-50. PubMed ID: 13978213
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.